Get it on Google Play

Kensey Nash (KNSY) Receives FDA Clearance for its First Extracellular Matrix Product, Medeor

November 11, 2009 12:16 PM EST Send to a Friend
Kensey Nash Corporation (Nasdaq: KNSY) announced that it has received 510(k) clearance for its first extracellular matrix (ECM) product, Medeor(TM) ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login